Nanometrics Incorporated, a leading supplier of advanced metrology equipment to the semiconductor industry, today announced the 1,000th shipment of its Integrated Metrology system, highlighting the company’s leadership position in the IM market for semiconductor manufacturing.
Nanobac Pharmaceuticals Inc. announces publication in the International Journal of Nanomedicine research that scientists from the University of California San Francisco collaborating with Nanobac scientists at NASA's Johnson Space Center have concluded demonstrating that calcium deposits in the human kidney called Randall's Plaque may in fact be Calcifying Nano Particles which lead to the formation of Kidney Stones.
Micromem Technologies Inc. announced its Magneto-resistive random access memory (MRAM) is a highly probable candidate for the universal memory, characterized mainly by high speed (read/write), high density and non-volatility. Micromem has designed a new process architecture for MRAM.
Nanosys, Inc. today announced the expansion and extension of its collaborative agreement with Sharp Corporation, of Osaka, Japan, for the development of nanostructured device technologies for use in large area electronics products incorporating Nanosys' proprietary nanotechnology. Under the terms of this agreement, Sharp will support increased development efforts at both Nanosys and Sharp.
AMAG Pharmaceuticals, Inc. today announced that the New Drug Application for ferumoxytol in chronic kidney disease has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is seeking marketing approval for ferumoxytol as an intravenous treatment of iron deficiency anemia in patients with CKD, including dialysis dependent and non-dialysis dependent patients.